MeMed
Israel, IL · 17 known investors
Find your way into MeMed
MeMed develops diagnostic tests that decode the host immune response to differentiate bacterial from viral infections in emergency settings. The company provides rapid immunoassay-based diagnostic tools for clinicians to improve patient outcomes and antibiotic stewardship.
Founders & leadership
Board
Investors · 17
Also in the syndicate · 11
Funding
SEC filings, press & company announcements$93M disclosed across 1 of 2 rounds · 2022
- Undisclosed amountSeries EJan 2022
Caesarea Medical Holdings, ClaI Insurance, Horizons Ventures, La Maison Partners, Phoenix Insurance, Poalim Equity, Shavit Capital, Social Capital, Touchwood Capital, Union Tech Ventures, Western Technology Investment
Source ↗ - $93MraisedJan 2022 · 2 sources
Horizon Ventures (lead), Bank Hapoalim, Caesarea Medical Holdings, Ceocial CapitalFund, Comet Capital, Kell Insurance, Phoenix, Touchwood CapitalFund, Union Tech Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does MeMed do?
- MeMed develops diagnostic tests that decode the host immune response to differentiate bacterial from viral infections in emergency settings. The company provides rapid immunoassay-based diagnostic tools for clinicians to improve patient outcomes and antibiotic stewardship.
- Who founded MeMed?
- MeMed was founded by Eran Eden.
- Who are MeMed's investors?
- MeMed's investors include Horizons Ventures, Metaplanet, Union Tech Ventures, Poalim Equity, Shavit Capital, Western Technology Investment.
- How much funding has MeMed raised?
- MeMed has disclosed $93M raised across 1 of its 2 known rounds.
- Where is MeMed headquartered?
- MeMed is headquartered in Israel, IL.